NRF2 regulates HER1 signaling pathway to modulate the sensitivity of ovarian cancer cells to lapatinib and erlotinib

Ibrahim Hamza Kankia, Hilal S. Khalil, Simon P. Langdon, Peter R. Moult, James L. Bown, Yusuf Y. Deeni*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    13 Citations (Scopus)
    62 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'NRF2 regulates HER1 signaling pathway to modulate the sensitivity of ovarian cancer cells to lapatinib and erlotinib'. Together they form a unique fingerprint.

    Chemical Compounds

    Medicine & Life Sciences